Literature DB >> 6576844

[Development of the risk of infection in the child with leukemia].

P Lutz, G Delage, G E Rivard, G Berdnikoff.   

Abstract

Infection is the leading cause of illness and death in children with leukemia. The risk of infection may change over time as regimens of therapy are modified. A review of the hospital charts of 166 infants in whom leukemia had been diagnosed between 1976 and 1980 revealed an increased number of deep fungal infections (20 v. 3) during this period in comparison with the number between 1969 and 1976 in 164 patients treated at the same hospital whose leukemia was diagnosed between 1969 and 1975. The 20 severe fungal infections between 1976 and 1980 were characterized by difficulty of diagnosis (a definite diagnosis having been made three times out of four only at autopsy), an important role of Candida but also of Aspergillus (the latter having been isolated almost as often as the former) and a grave prognosis (the mortality being very high [75%] and much above that for gram-positive septicemia [6%] and that for gram-negative septicemia [31%]). This increase in frequency of fungal infections was concurrent with the introduction of phase-1 chemotherapy, which was often responsible for prolonged neutropenia. To reduce the risk of infection in children with leukemia it appears to be essential to improve diagnostic methods and approaches to therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6576844      PMCID: PMC1875185     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Phase I study on 5-aza-2'-deoxycytidine in children with acute leukemia.

Authors:  G E Rivard; R L Momparler; J Demers; P Benoit; R Raymond; K Lin; L F Momparler
Journal:  Leuk Res       Date:  1981       Impact factor: 3.156

2.  [Infections in the leukemic child (retrospective study of 164 cases)].

Authors:  Y de Clerck; D de Clerck; G E Rivard
Journal:  Union Med Can       Date:  1978-08

3.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

Authors:  P A Pizzo; K J Robichaud; F A Gill; F G Witebsky
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

Review 4.  Pulmonary infections in the immunocompromised patient.

Authors:  R A Matthay; W H Greene
Journal:  Med Clin North Am       Date:  1980-05       Impact factor: 5.456

5.  Infectious complications in the child with cancer. II. Management of specific infectious organisms.

Authors:  P A Pizzo
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

6.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

7.  Septicemia in association with acute lymphoblastic leukemia.

Authors:  R R Chilcote; R L Baehner
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

8.  Nosocomial infections in the immunocompromised adult.

Authors:  L S Young
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

9.  Causes of death in adults with acute leukemia.

Authors:  H Y Chang; V Rodriguez; G Narboni; G P Bodey; M A Luna; E J Freireich
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

10.  Infections in children with malignant disease in Argentina.

Authors:  E López; L Fernández Perona; R Rocco; M del Valle; R H Estévez; J L Braier; A Speranza; J P Wasserman; H Arroyo; S Grinstein; A Schugurensky; N F Bonesana; E Rubeglio; G Muchinik; F Sackmann-Muriel
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

View more
  1 in total

1.  [Septicemia in leukemia and malignant lymphoma. Incidence pathogens--causes].

Authors:  H H Hennemann
Journal:  Klin Wochenschr       Date:  1985-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.